Synokem Pharmaceuticals Executive and Leadership Team

August, 2026

Leadership Overview

Synokem Pharmaceuticals has 6 executives leading key functions including international exports, corporate strategy, drug regulatory affairs, clinical development, institutional supply management, and ethical marketing operations.

Focused on delivering affordable healthcare solutions, Synokem Pharmaceuticals prioritizes research-driven manufacturing and global market expansion to improve accessibility for diverse patient populations worldwide.

Leadership Roles at Synokem Pharmaceuticals

  • President - Exports - Pankaj Synokempharma
  • President - Surender Arora
  • President, Drug Regulatory Affairs, Clinical Development - Aditya Kaushik
  • President - Rajan Mahendru
  • President - Rajat Adhikari
  • President - Sandeep Soni
  • Pankaj Synokempharma - President - Exports

    Pankaj Synokempharma, the President - Exports at Synokem Pharmaceuticals, directs all international business development and global distribution strategies. Overseeing the expansion of pharmaceutical exports into emerging markets, the President - Exports ensures compliance with diverse international regulatory standards while maximizing market penetration. This leadership role involves managing complex supply chain logistics to maintain consistent product availability across multiple continents. By forging strategic alliances with foreign distributors, Pankaj Synokempharma drives significant revenue growth and strengthens the global footprint of the organization. The President - Exports collaborates closely with the manufacturing division to align production schedules with international demand forecasts. Through rigorous market analysis and proactive relationship management, the President - Exports secures long-term partnerships that solidify the company position as a reliable supplier in the global pharmaceutical landscape, ultimately enhancing the reach of affordable medicine.

    Surender Arora - President

    Surender Arora, the President at Synokem Pharmaceuticals, architects the overarching corporate strategy and operational framework for the entire organization. Overseeing internal scaling and organizational efficiency, the President ensures that all departments align with the core mission of providing affordable, high-quality pharmaceutical products. This leadership role involves constant evaluation of market trends to guide investment in research and development initiatives. By optimizing internal processes, Surender Arora drives operational excellence and supports the company goal of becoming a world-class manufacturer. The President maintains direct oversight of institutional supply channels, ensuring that large-scale contracts meet strict quality and delivery benchmarks. Through consistent monitoring of performance metrics, the President fosters a culture of accountability and innovation. Ultimately, Arora secures the financial health of the company by balancing aggressive growth targets with sustainable manufacturing practices, ensuring long-term stability within the competitive pharmaceutical industry.

    Aditya Kaushik - President, Drug Regulatory Affairs, Clinical Development

    Aditya Kaushik, the President, Drug Regulatory Affairs, Clinical Development at Synokem Pharmaceuticals, manages the complex lifecycle of pharmaceutical product approval and clinical research. Overseeing the navigation of stringent regulatory landscapes, the President, Drug Regulatory Affairs, Clinical Development ensures that every product meets safety and efficacy standards required for market entry. This leadership role involves designing clinical trial protocols and supervising data collection to validate new drug formulations. By maintaining transparent communication with health authorities, Aditya Kaushik facilitates the rapid approval of essential medications. The President, Drug Regulatory Affairs, Clinical Development coordinates with the research team to translate scientific breakthroughs into viable commercial products. Through meticulous documentation and adherence to global compliance protocols, the President, Drug Regulatory Affairs, Clinical Development mitigates risk and accelerates the time-to-market for new therapies, directly contributing to the company reputation for quality and scientific integrity.

    Rajan Mahendru - President

    Rajan Mahendru, the President at Synokem Pharmaceuticals, directs the strategic expansion of contract manufacturing services and institutional partnerships. Overseeing the operational capacity of manufacturing facilities, the President ensures that production lines meet the high-volume demands of institutional clients while maintaining strict quality control. This leadership role involves negotiating large-scale supply agreements and managing relationships with key healthcare providers. By streamlining the manufacturing process, Rajan Mahendru enhances production efficiency and reduces costs, allowing the company to offer more competitive pricing. The President collaborates with the research team to integrate new technologies into the manufacturing workflow, ensuring that the company remains at the forefront of pharmaceutical production. Through focused efforts on operational scalability, the President supports the broader organizational goal of increasing market share. Ultimately, Mahendru drives the company success by delivering consistent, high-quality pharmaceutical supplies to institutional partners across the region.

    Rajat Adhikari - President

    Rajat Adhikari, the President at Synokem Pharmaceuticals, leads the ethical marketing division and domestic market development initiatives. Overseeing the promotion of pharmaceutical products to healthcare professionals, the President ensures that all marketing strategies adhere to ethical standards and regulatory guidelines. This leadership role involves developing educational programs that highlight the efficacy and affordability of the company product portfolio. By analyzing regional market data, Rajat Adhikari identifies growth opportunities and tailors marketing campaigns to meet the specific needs of diverse patient demographics. The President coordinates with the sales force to ensure effective product positioning and brand awareness. Through strategic engagement with the medical community, the President fosters trust and long-term loyalty among healthcare providers. Ultimately, Adhikari drives revenue growth by expanding the presence of the company in the domestic market, ensuring that high-quality medications reach the sections of society that need them most.

    Sandeep Soni - President

    Sandeep Soni, the President at Synokem Pharmaceuticals, manages the integration of research and development outcomes into the commercial product pipeline. Overseeing the transition from laboratory innovation to full-scale production, the President ensures that new pharmaceutical offerings align with the company vision of quality and affordability. This leadership role involves coordinating between the research scientists and the manufacturing teams to resolve technical challenges and optimize formulation stability. By prioritizing investment in cutting-edge technology, Sandeep Soni drives the development of a robust product portfolio that addresses unmet medical needs. The President monitors industry advancements to ensure that the company remains competitive in a rapidly evolving market. Through effective resource allocation and project management, the President accelerates the development cycle of new products. Ultimately, Soni secures the future growth of the organization by fostering a culture of continuous improvement and scientific excellence in every product launch.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding Synokem Pharmaceuticals Top Executives and Leadership Team

    Who leads Synokem Pharmaceuticals?
    Synokem Pharmaceuticals is led by Pankaj Synokempharma (President - Exports), along with executives such as Surender Arora (President) and Aditya Kaushik (President, Drug Regulatory Affairs, Clinical Development).
    Who is part of Synokem Pharmaceuticals’s executive team?
    The executive team of Synokem Pharmaceuticals includes leaders such as Pankaj Synokempharma (President - Exports), Surender Arora (President), Aditya Kaushik (President, Drug Regulatory Affairs, Clinical Development) and other senior executives.
    How many executives does Synokem Pharmaceuticals have?
    Synokem Pharmaceuticals has 6 executives leading key business areas.
    What roles are included in Synokem Pharmaceuticals’s leadership team?
    The leadership team of Synokem Pharmaceuticals includes roles such as President - Exports, President, President, Drug Regulatory Affairs, Clinical Development, President, President.